Healthcare venture capitalists are no fans of the U.S. Food and Drug Administration and the regulatory challenges the agency poses for medical startups and device companies.
They blame many of the problems besetting healthcare investing squarely on the agency as delays caused by reviewers push investor pay day further out.
What Are the Best Medical Coding Outsourcing Companies?
Outsourcing your medical coding can help ensure a healthy revenue cycle. Discover the best medical coding outsourcing companies and find the right one for you.
But at the MedTech Investing Conference in Minneapolis on Monday, moderator Bill Harrington, managing partner at Osage University Partners, half jokingly cautioned that there will be no whining on the matter.
And at least one panelist on a session discussing where medical tech VCs are investing took him seriously.
After a short complaint about the FDA coming from another panelist — John Ryan of Onset Ventures — Juliet Bakker, founder and managing director of Longitude Capital, said that her advice to portfolio companies is to be always be respectful of the FDA.
“After all, they are here to protect us,” she said.
The 5 Best Software to Buy for Managing a Spa Franchise
Choosing the right software translates directly into better client management, operational efficiency and growth for your spa franchise. Discover which tool is best for your business.
Bakker added that on many occasions companies and regulatory consultants don’t ” bother to answer the questions that the FDA has asked” or give the answers that they want to give. That, she said, creates delays. And delays are anathema to the venture capital and startup community eager to see a return on investment.
“The better part of valor is to respect the FDA” Bakker said.
“Great advice” said Harrington, before moving to the next question.
[Photo Credit: sippakorn]